Q32 Bio Inc. (QTTB) Return on equity 2018–2025
Q32 Bio Inc. (QTTB) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
71.0%FY2025 · since FY2018: -28.3% → 71.0%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 71.0% | +912.1 pp |
| FY2024 | -841.1% | — |
| FY2021 | -56.4% | +9.2 pp |
| FY2020 | -65.7% | -25.5 pp |
| FY2019 | -40.2% | -11.9 pp |
| FY2018 | -28.3% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More QTTB financial trends
QTTB RevenueQTTB Net incomeQTTB Net marginQTTB Gross profitQTTB Gross marginQTTB Operating incomeQTTB Operating marginQTTB Operating cash flowQTTB Free cash flowQTTB Capital expendituresQTTB Stock buybacksQTTB Dividends paidQTTB Total assetsQTTB Total liabilitiesQTTB Shareholders’ equityQTTB overview →